Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Stock Report

| More

ICRA upgrades rating and outlook of Lincoln Pharmaceuticals Ltd

Posted On: 2021-02-22 05:02:55 (Time Zone: Arizona, USA)


The rating agency ICRA Ltd has upgraded ratings and outlook of Lincoln Pharmaceuticals Ltd. ICRA has upgraded rating of company's long-term bank loan facilities to ICRA A with stable outlook from ICRA A- and positive outlook. Short term bank loan facilities of the company were upgraded to ICRA A1 from ICRA A2+ earlier. Rating agency in its report has stated that the upgrade in ratings takes into account the improvement in the group's financial risk profile in FY2020 and 9MFY2021, backed by steady growth in scale and margins.

ICRA in its report stated that, Stable outlook on the [ICRA]A rating reflects ICRA's opinion that the Group will continue to benefit from the extensive experience of its promoters in the pharmaceutical formulations industry and is likely to witness revenue growth in the near to medium term. The revenue growth will be backed by stable demand conditions for its existing products in the domestic and semi regulated export market, planned venture into the regulated European market as well as the proposed launch of beta lactam products, for which the company proposes to set up a new unit.

"Our company is growing from strength to strength and delivering robust operational and financial performance while maintaining healthy growth in revenue, margins and profitability and expects to continue the growth momentum in the coming years. Our strategic growth initiatives, product and geographical expansion, EU approval, operational efficiency are likely to maximise value for all stakeholders in the near to medium term. Upgrade by ICRA for company's long-term and short-term ratings further testifies the strong foundation of the group," said Mr. Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Limited.

ICRA report also states that, Group has no long-term debt outstanding as on September 30, 2020. Healthy profitability and limited capex outgo have improved the coverage indicators and liquidity, resulting in healthy built up of free cash/liquid investments.

During the FY20, company paid all its outstanding debt to the Financial Institution and now it has become a zero net-debt company. Company has received EU approval and plans to enter the EU markets very soon with its dermatology, gastro and pain management products. Company currently exports to more than 60 countries and plans to expand to 90 plus countries.

For the nine months ended December 2020, the company has posted a net profit of Rs. 48.6 crore as against net profit of Rs. 40.3 crore, growth of 20.7%. Net revenue also grew by 10% Y-o-Y to Rs. 339.8 crore in nine months ended December 2020.

Shares of LINCOLN PHARMACEUTICALS LTD. was last trading in BSE at Rs.221.8 as compared to the previous close of Rs. 222.7. The total number of shares traded during the day was 12665 in over 459 trades.

The stock hit an intraday high of Rs. 227.8 and intraday low of 220.5. The net turnover during the day was Rs. 2828023.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Other Headlines:

Indiabulls Housing Finance Ltd. ties up with HDFC Ltd. for Co-Lending Partnership

Tejas Networks Ltd Q4FY21 consolidated PAT soars to Rs. 33.55 crore

ICICI Securities Ltd reports Rs. 329.47 crore consolidated PAT in Q4FY21

Phillips Carbon Black Ltd posts consolidated PAT of Rs. 127.73 crores in Q4FY21

Wonderla announces closure of Bangalore Park till May 4

Hero MotoCorp and Gogoro® Inc announce strategic partnership

Three ONGC employees abducted by armed miscreants in Sivasagar, Assam

Indigo Paints Limited board to approve Q3, Q4, FY21 results on May 14, 2021

Coromandel International Ltd board to announce Q4, FY21 results on April 29, 2021

Hathway Cable & Datacom Ltd board to consider FY21 results on April 28, 2021

Seshasayee Paper and Boards Ltd board to approve FY21 results on May 8, 2021

Rossari Biotech Limited allots 30,12,046 Equity Shares at Rs. 996 per share

Ajanta Pharma Ltd board to consider Q4, FY21 results on April 30, 2021

Maruti Suzuki India Ltd introduces New version of RPAS System in Eeco Cargo Variants

KEC International wins New Orders of Rs. 1,245 crores

MTAR Technologies Limited: Ratings upgraded, outlook revised to Positive

ACC unveiled a new range of innovative and sustainable products during COVID-19

Supreme Industries Ltd board to approve dividend, FY21 results on May 3, 2021

Mastek Ltd board to consider final dividend, FY21 results on April 28, 2021

Enkei Wheels (India) Ltd board to announce quarterly results on April 28, 2021

ICICI Securities board recommends final dividend of Rs. 13.50

TCS Named a Leader in the 2021 Gartner Magic Quadrant for Managed Workplace Services, Asia Pacific

Shri Bajrang Alliance Limited's Agro Division now certified under Food Safety Management System

5Paisa Capital Ltd Q4FY21 consolidated net profit surges to Rs. 5.85 crore

Accelya Solutions India Ltd board to consider Q3FY21 results on April 30, 2021

Van Heusen launches new sub-brand 'Denim Labs'

Shriram City Union Finance Ltd board to approve final dividend, FY21 results on April 30, 2021

Larsen & Toubro Infotech Ltd board to conider Q4, FY21 results, dividend on May 4, 2021

Cipla Ltd board to consider Q4, FY21 results, dividend on May 14, 2021

Tata Steel Long Products Ltd Board approves dividend of Rs. 5

Swaraj Engines Limited announces Q4FY21 results

AstraZeneca Pharma India Limited launches Fasenra™

Hero MotoCorp to undertake temporary suspension of manufacturing operations as precautionary measure

Salasar Techno Engineering Ltd receives orders worth Rs. 47.70 crore

Supreme Petrochem Ltd Board to consider FY21 results & Dividend on April 30, 2021

IRDAI imposes penalty of Rs. 25 lacs on SBI General Insurance Company Limited

Tata Steel Long Products Ltd Q4FY21 consolidated PAT soars to Rs. 339.86 crore

Network18 Media & Investments Ltd reports Rs. 39.13 crore consolidated PAT in Q4FY21

Quick Heal Technologies Ltd fixes May 3, 2021 as record date for Buy Back

TV18 Broadcast Ltd reports Q4FY21 consolidated PAT of Rs. 165.88 crore

Swaraj Engines Ltd Board approves dividend of Rs. 50, special dividend of Rs. 19

Blue Dart Express Ltd board to consider Q4, FY21 results, dividend on May 5, 2021

Swaraj Engines Ltd Q4FY21 PAT surges to Rs. 32.56 crore

Narendra Investments Delhi Ltd Q4FY21 PAT up at Rs. 0.35 crore

Nestle India Ltd reports jump in net profit to Rs. 602.25 crore in Q1CY21

Central Bank of India board approves issue of shares at Rs. 17.11

Saregama strikes a long term music deal with Sanjay Leela Bhansali

Nestle India Ltd board declares interim dividend of Rs. 25 for CY2021

TCI Industries Limited approves issue of 107602 NCRPS

Alembic Pharmaceuticals Ltd board to consider Q4, FY21 results on March 31, 2021


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020